Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
L01XX41
|
| gptkbp:CASNumber |
162913-54-0
|
| gptkbp:chemicalFormula |
C27H36N4O2
|
| gptkbp:developedBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:genericName |
gptkb:tipifarnib
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zarnestra
|
| gptkbp:mechanismOfAction |
farnesyltransferase inhibitor
|
| gptkbp:regulates |
investigational
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:R115777
|
| gptkbp:target |
gptkb:farnesyltransferase
|
| gptkbp:usedFor |
gptkb:acute_myeloid_leukemia
solid tumors myelodysplastic syndromes |
| gptkbp:bfsParent |
gptkb:tipifarnib
|
| gptkbp:bfsLayer |
7
|